Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

Our pledge: industry-leading action for the climate

Strong results in Q3 as we Focus. Together. For patients & society.

Reuters Events Pharma 2021: Transforming Medical Affairs to drive patient value

Rethinking risk factors this Liver Cancer Awareness Month